LPCN

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Lipocine (LPCN) Earnings Date & Reports

Lipocine Inc is a clinical-stage biopharmaceutical company... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

LPCN is expected to report earnings to rise 962.50% to -42 cents per share on August 09

Q2'23

Est.

$-0.43

Q1'23

Missed

by $0.01

Q4'22

Missed

by $0.31

Q3'22

Missed

by $0.48

Q2'22

Missed

by $0.64

The last earnings report on May 11 showed earnings per share of -3 cents, missing the estimate of -2 cents. With 41.27K shares outstanding, the current market capitalization sits at 16.96M.

View a ticker or compare two or three

Compare

LPCN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For LPCN
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of pharmaceutical products

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Other

Address

675 Arapeen Drive

Phone

+1 801 994-7383

Employees

Web

https://www.lipocine.com